We recently performed a systematic review of the safety of radiation therapy in patients with prostate cancer and a diagnosis of inflammatory bowel disease. Three studies, accounting for 42% of the evaluable patients, profiled the treatment of patients with hypofractionation (n = 5/8 in Vanneste et ...

Our experience is favorable as well. We have treated a number of patients with well controlled IBD using a spacer and SBRT. We have not seen more toxicity than with other patients. It is helpful to establish a dialogue with the treating gastroenterologist as you are making decisions with the patient...

Depends on how hypofractionated. Would advise conventional.